NCT06873828View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter Monitoring

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Hypertrophic Cardiomyopathy
Interventions
DEVICE

ATP-C135

A wearable long-term electrocardiogram monitoring device that monitors electrocardiograms by attaching it for up to 14 days.

DEVICE

ATP-C75

A wearable long-term electrocardiogram monitoring device that monitors electrocardiograms by attaching it for up to 7 days.

All Listed Sponsors
lead

Yonsei University

OTHER